Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Leukemia|June 2, 2007
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsK Le Blanc, H Samuelsson, B Gustafsson, et al.Clinical Lymphoma, Myeloma & Leukemia|June 23, 2021
Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free SurvivalM M Ali, B Grønvold, M Remberger, et al.Journal of Clinical Microbiology|November 6, 2004
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantationG Bogdanovic, P Priftakis, G Giraud, et al.Bone Marrow Transplantation|November 25, 1998
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysisS Carlens, O Ringdén, M Remberger, et al.Bone Marrow Transplantation|January 8, 2008
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantationL Barkholt, M Remberger, Z Hassan, et al.Blood|March 26, 1999
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation GroupO Ringdén, M Remberger, T Ruutu, et al.Bone Marrow Transplantation|January 6, 2004
Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokinesN Ihendyane, E Sparrelid, B Wretlind, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2009
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reactionH Omar, H Hägglund, A Gustafsson-Jernberg, et al.Transplantation|June 14, 2000
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancerO Ringdén, G Söderdahl, J Mattsson, et al.Journal of Internal Medicine|February 26, 2013
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantationO Ringdén, T Erkers, J Aschan, et al.Pageof 12